Navigation Links
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Date:10/26/2007

Interim Results From Open-Label Follow-up Include Longer-term Safety

Findings

BOSTON, Oct. 26 /PRNewswire/ -- Adults with Attention Deficit Hyperactivity Disorder (ADHD) treated with CONCERTA(R) OROS(R) methylphenidate HCl Extended-release Tablets showed significant improvements in ADHD symptom management compared to adults taking placebo, according to study results presented today at a major psychiatric medical meeting.

"Pharmacological treatment of children and adolescents with ADHD is clearly established but relatively less is known about the treatment of adults with ADHD," notes the study's medical director, Sally Berry, M.D., PhD., of Johnson & Johnson Pharmaceutical Research and Development, LLC. "We're encouraged that the CONCERTA(R) findings presented today -- in which CONCERTA(R) significantly improved ADHD symptom management in adults -- can benefit the growing body of knowledge in this important therapeutic area." The data presented today are part of a Supplemental New Drug Application (sNDA) submitted in August 2007 to the Food and Drug Administration for use of CONCERTA(R) to treat adults with ADHD. CONCERTA(R) is already approved for the treatment of ADHD in children and adolescents ages six to 17.

About the Study

In the study presented today, efficacy was measured as a change in the Adult ADHD Investigator Symptom Rating Scale (AISRS) total score. The results showed that CONCERTA(R) achieved a significantly superior reduction in AISRS total score compared to placebo (p=0.012) (mean change was -10.6 +/-1.09 for the CONCERTA(R) group vs. -6.8 +/-1.06 for the placebo group.

In addition, CONCERTA(R) was significantly superior compared to placebo for the key secondary efficacy variables: change in Clinical Global Impression-Improvement (CGI-I) rating (p=0.008); change in Conners' Adult ADHD Rating Scale-Self Report (CAARS-S:S) total score (p=0.029) and change in percent of subjects m
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  This industry report package offers the most ... for safety glass in the world and in the top 10 global ... country reports from the following countries: Australia ... Germany , Italy , Japan ... United Kingdom , United States ...
(Date:3/3/2015)... March 3, 2015  UnaliWear announces the market preview ... for seniors that guards against wandering and provides support ... new wearable – the Kanega watch ( http://www.UnaliWear.com ) ... use an easy speech interface rather than buttons, use ... human input. The watch goes wherever ...
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2
... BANGALORE, KARNATAKA, India, Oct. 19 Cardiac Science Corporation (Nasdaq: ... Code: 532391; NSE: OPTOCIRCUI] today announced they have entered into ... to acquire all of the outstanding shares of Cardiac Science ... represents a 10% premium to the closing price of Cardiac ...
... SAN DIEGO, Oct. 18 Althea Technologies, Inc., ... for biopharmaceuticals and parenteral drug products, announced today ... new INOVA H3-5 high-speed syringe filling line.  This ... commercial manufacturing facility in San Diego. The expanded ...
Cached Medicine Technology:Opto Circuits to Acquire Cardiac Science 2Opto Circuits to Acquire Cardiac Science 3Opto Circuits to Acquire Cardiac Science 4Opto Circuits to Acquire Cardiac Science 5Opto Circuits to Acquire Cardiac Science 6Opto Circuits to Acquire Cardiac Science 7Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 On February ... complaint in the United States District Court for the ... Financial Freedom, as well as insurance companies Balboa, QBE, ... 2015 in Case No. 3:14-cv-152.) , The Plaintiff, a ... insurance companies to force her to buy too much ...
(Date:3/3/2015)... 2015 Longtime parent visionary and inspiring ... Surrogacy Center for a candid interview on the ... is an exhilarating revelation of his magical surrogacy journey ... from Australia to the birth of his precious twin ... Umar, CEO and Founder of CARE stated, “We are ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles ... crimes, recently spoke on the radio to give his insights ... the Independent Journal Review radio show “The Right Mics” chose ... prosecutor and now as a criminal defense attorney would provide ... trial and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... (PRWEB) March 04, 2015 The report ... on the therapeutic development for Alopecia. Alopecia is the ... the two main types of alopecia. Causes for alopecia ... Symptoms of alopecia may include male pattern hair loss, ... hair. Alopecia can be classified as focal or diffuse ...
(Date:3/3/2015)... 2015 The first week of March ... Foundation. The event brings recognition to a rarely discussed ... According to the Centers for Disease Control , ... form or another. Too little or unrestful sleep is ... illness and depression, and even a higher likelihood of ...
Breaking Medicine News(10 mins):Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3
... ... tobacco, MINNEAPOLIS, Nov. 14 ... Begun in Monticello,Minnesota, and now supported nationwide by the American Cancer Society, ... "The Great American Smokeout is rooted in Minnesota, so it,s fitting,that ...
... asthma patients avoid fracture, researchers say , , WEDNESDAY, ... has proven superior to standard therapy at slowing ... , Glucocorticoid medicines such as prednisone are often ... and other conditions, researchers note. But the drugs ...
... College of Wisconsin in Milwaukee have found that the ... may be reduced by a drug in common use. ... issue of the International Journal of Radiation Oncology, Biology ... the drug captopril, starting at three weeks after patients ...
... added survival remains unclear, scientists say , , WEDNESDAY, Nov. ... live longer following an Alzheimer,s diagnosis than white patients, ... of Asian and American Indian descent diagnosed with the ... that of white Alzheimer,s patients, patients of Hispanic ...
... Community Hospital of Long Beach (CHLB) is entering to win a ... The hospital that receives the most ... scanner. Voting is taking place NOW through December 31, ... select ,Community Hospital of Long ...
... Dynatronics,Corporation (Nasdaq: DYNT ) will release financial results ... of Monday, November 19, 2007.,The Company filed an extension ... statements due to the six acquisitions that were,made on ... has scheduled a conference call for investors at 1:30 ...
Cached Medicine News:Health News:ClearWay Minnesota(SM) to Share Stories of Real Minnesotans Who Used QUITPLAN(R) Services During Great American Smokeout 2Health News:New Drug Fights Medication-Linked Bone Loss 2Health News:Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 3Health News:Blacks, Hispanics Live Longer With Alzheimer's 4Health News:Community Hospital of Long Beach - Help Us Win an MRI Scanner! 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: